Market closedNon-fractional

Galectin Therapeutics/GALT

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Galectin Therapeutics

Ticker

GALT

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Norcross, United States

Employees

14

GALT Metrics

BasicAdvanced
$154M
Market cap
-
P/E ratio
-$0.74
EPS
0.65
Beta
-
Dividend rate
$154M
0.65
2.015
1.865
-118.649
-118.717
-11.05%
-101.32%
72.15%
-2.11
-2.11
-4.398
8.12%
16.79%

What the Analysts think about GALT

Analyst Ratings

Majority rating from 1 analysts.
Buy

GALT Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$11M
15.15%
Profit margin
0.00%
NaN%

GALT Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 18.75%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.15
-$0.24
-$0.16
-$0.19
-
Expected
-$0.21
-$0.16
-$0.16
-$0.16
-$0.16
Surprise
-28.57%
50.00%
0.00%
18.75%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Galectin Therapeutics stock?

Galectin Therapeutics (GALT) has a market cap of $154M as of July 23, 2024.

What is the P/E ratio for Galectin Therapeutics stock?

The price to earnings (P/E) ratio for Galectin Therapeutics (GALT) stock is 0 as of July 23, 2024.

Does Galectin Therapeutics stock pay dividends?

No, Galectin Therapeutics (GALT) stock does not pay dividends to its shareholders as of July 23, 2024.

When is the next Galectin Therapeutics dividend payment date?

Galectin Therapeutics (GALT) stock does not pay dividends to its shareholders.

What is the beta indicator for Galectin Therapeutics?

Galectin Therapeutics (GALT) has a beta rating of 0.65. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Galectin Therapeutics stock

Buy or sell Galectin Therapeutics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing